Related references
Note: Only part of the references are listed.lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin
Xinyi Wang et al.
EMBO REPORTS (2022)
Exosomal transfer of circ_0006174 contributes to the chemoresistance of doxorubicin in colorectal cancer by depending on the miR-1205/CCND2 axis
Yan Zhang et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer
Bingqing Hui et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Smart Hydrogels for Advanced Drug Delivery Systems
Aydin Bordbar-Khiabani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop
Xiaomin Li et al.
MOLECULAR CANCER (2022)
N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming
Kun Zhang et al.
THERANOSTICS (2022)
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
Eluri Pavitra et al.
SEMINARS IN CANCER BIOLOGY (2021)
Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines
Ga-Young Lee et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2021)
Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer
Dongdong Luo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis
Lanlan Xi et al.
CANCER CELL INTERNATIONAL (2021)
miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4
Mohammad Reza Mohammad Hoseini Azar et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer
Huanrong Lan et al.
MOLECULAR PHARMACEUTICS (2021)
Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell
Ziyuan Wang et al.
PHYTOMEDICINE (2021)
Exosome-Based Delivery of Natural Products in Cancer Therapy
Hang Song et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Epigenetic Remodeling Hydrogel Patches for Multidrug-Resistant Triple-Negative Breast Cancer
Xiaoyuan Ji et al.
ADVANCED MATERIALS (2021)
GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis
Jing Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer
Shunhao Zhang et al.
CANCER MEDICINE (2021)
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis
Su-Jie Gao et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Cascaded amplification of intracellular oxidative stress and reversion of multidrug resistance by nitric oxide prodrug based-supramolecular hydrogel for synergistic cancer chemotherapy
Jimin Zhang et al.
BIOACTIVE MATERIALS (2021)
Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p
Kui Zhao et al.
MOLECULAR AND CELLULAR BIOLOGY (2021)
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
L. E. Anselmino et al.
SCIENTIFIC REPORTS (2021)
Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLFI2 Axis
Weitong Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation
Laura Mosca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells
Zi-Ning Lei et al.
MEDCOMM (2021)
Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p
Yeqing Xu et al.
NEOPLASMA (2021)
Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment
Chunyang Jiang et al.
CLINICAL GENETICS (2020)
Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells
Xuan Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer
Heyu Song et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
Tzu-Tang Wei et al.
ONCOGENE (2020)
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
Yu Liang et al.
ONCOGENE (2020)
MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39
Yu Liang et al.
BRITISH JOURNAL OF CANCER (2020)
FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
Chao Liu et al.
CANCER LETTERS (2020)
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
Zhipeng Liu et al.
CANCER LETTERS (2020)
MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
Fei Xu et al.
CANCER SCIENCE (2020)
Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway
Yiyi Zhang et al.
EXPERIMENTAL CELL RESEARCH (2020)
miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer
Yu-Zhu Wu et al.
JOURNAL OF GENE MEDICINE (2020)
A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer
Yajun Jiang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
Ye Zhang et al.
AGING-US (2020)
MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer
Yi Yao et al.
BIOSCIENCE REPORTS (2020)
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
Zeting Yuan et al.
BRITISH JOURNAL OF CANCER (2020)
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Gaofeng Liang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer
Ziyuan Wang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells
Chao Liu et al.
CANCER MEDICINE (2020)
β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest
Ruonan Zhang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer
Yu-Hang Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway
Pei Zhang et al.
GENE (2020)
Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance
Surui Yao et al.
CANCER MEDICINE (2020)
Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress
Yi Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance
Weifeng Xu et al.
CANCER CELL INTERNATIONAL (2020)
LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer
Yong-Liang Du et al.
EXPERIMENTAL CELL RESEARCH (2020)
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance
Chi Chun Wong et al.
GASTROENTEROLOGY (2020)
Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway
Hao Chen et al.
ONCOTARGETS AND THERAPY (2020)
Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins
Yushan Yang et al.
CELL DEATH & DISEASE (2020)
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
Hai-Ling Gao et al.
FRONTIERS IN ONCOLOGY (2020)
Circ_0007031 enhances tumor progression and promotes 5-fluorouracil resistance in colorectal cancer through regulating miR-133b/ABCC5 axis
Xiaowen He et al.
CANCER BIOMARKERS (2020)
The Interplay between Fe3O4 Superparamagnetic Nanoparticles, Sodium Butyrate, and Folic Acid for Intracellular Transport
Maria Teresa Cambria et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway
Tao Yu et al.
LIFE SCIENCES (2020)
The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer
Wu Sun et al.
THERANOSTICS (2020)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
Mohammad B. Uddin et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Treatment sequencing in metastatic colorectal cancer
D. P. Modest et al.
EUROPEAN JOURNAL OF CANCER (2019)
Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel
Yutao Ren et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells
Ruijuan Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
Daisuke Izumi et al.
CELL DEATH & DISEASE (2019)
Nonsteroidal Anti-Inflammatory Drugs Prevent Vincristine-Dependent Cancer-Associated Fibroblasts Formation
Marta Ewelina Wawro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
Ladan Mashouri et al.
MOLECULAR CANCER (2019)
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
J. L. Hu et al.
MOLECULAR CANCER (2019)
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-B pathway
Lu Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Srinivas Patnaik et al.
FRONTIERS IN PHARMACOLOGY (2019)
Carrier-Free Supramolecular Hydrogel Composed of Dual Drugs for Conquering Drug Resistance
Chunhua Ren et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
miR-133b suppresses colorectal cancer cell sternness and chemoresistance by targeting methyltransferase DOT1L
Lv Lv et al.
EXPERIMENTAL CELL RESEARCH (2019)
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer
Nanzheng Chen et al.
PLOS ONE (2019)
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
Liye Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway
Yonggang Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
Jinbo Fu et al.
SCIENTIFIC REPORTS (2019)
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Mohammad Najlah et al.
PHARMACEUTICS (2019)
Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells
Aki Sakatani et al.
CARCINOGENESIS (2019)
Overexpressed methvItransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR149-3p/S100A4/p53 axis
Yang Liu et al.
AGING-US (2019)
Evaluation of cisplatin-hydrogel for improving localized antitumor efficacy in gastric cancer
Keyang Qian et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
A thermo-responsive alginate nanogel platform co-loaded with gold nanoparticles and cisplatin for combined cancer chemo-photothermal therapy
Mehri Mirrahimi et al.
PHARMACOLOGICAL RESEARCH (2019)
MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression
Meihui Huang et al.
JOURNAL OF CANCER (2019)
Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
Chun Yang et al.
BMC MOLECULAR AND CELL BIOLOGY (2019)
Enhanced local cancer therapy using a CA4P and CDDP co-loaded polypeptide gel depot
Shuangjiang Yu et al.
BIOMATERIALS SCIENCE (2019)
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species
Lei Xu et al.
BIOMATERIALS SCIENCE (2019)
Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
Sanhong Li et al.
APOPTOSIS (2018)
Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation
Qi Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer
Chun Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Overcoming sternness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling
Yinghu Jin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116
Egle Kukcinaviciute et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Noah Isakov
SEMINARS IN CANCER BIOLOGY (2018)
Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell
Yiyi Zhang et al.
ONCOTARGETS AND THERAPY (2018)
The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism
Gui-wei Liu et al.
HUMAN CELL (2018)
Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth
Ana S. Pires et al.
FRONTIERS IN PHYSIOLOGY (2018)
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR)
Liming Chang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
Zeting Yuan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Overcoming Drug Resistance in Colon Cancer by Aptamer-Mediated Targeted Co-Delivery of Drug and siRNA Using Grapefruit-Derived Nanovectors
Wei Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
Salvianolic acid B reverses multidrug resistance in HCT-8/VCR human colorectal cancer cells by increasing ROS levels
Piaoting Guo et al.
MOLECULAR MEDICINE REPORTS (2017)
Mechanism of reversal of multidrug resistance by curcumin in human colorectal cancer cell line HCT-8/5-FU
Y. X. Fan et al.
GENETICS AND MOLECULAR RESEARCH (2017)
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
Yanqing Liu et al.
MOLECULAR CANCER (2017)
Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway
Bing Liu et al.
MOLECULAR CARCINOGENESIS (2017)
Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells
Sung-Hee Kim et al.
ONCOTARGET (2017)
Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
Rashidah Baharudin et al.
FRONTIERS IN PHARMACOLOGY (2017)
Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study
Yi-Jun Wang et al.
CANCER LETTERS (2017)
miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression
Hui Zhou et al.
CELL PROLIFERATION (2017)
The Plasma microRNA miR-1914*and-1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-Regulating NFIX
J. Hu et al.
CURRENT MOLECULAR MEDICINE (2016)
Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism
Shengchao Lin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer
Hua Sui et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells
JaeJin An et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Myung Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway
Haitao Guan et al.
TUMOR BIOLOGY (2016)
PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma
Shuhua Wu et al.
TUMOR BIOLOGY (2016)
Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer
Constanze Buhrmann et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines
Karolina Wojtowicz et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Inhibition of CD 147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells
Jie Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles
Lijue Chen et al.
NANOSCALE (2015)
Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity
Tao Hu et al.
PHYTOMEDICINE (2015)
Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance
Joao Conde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity
Ziyuan Wang et al.
TUMOR BIOLOGY (2015)
Knockdown of β3GnT8 reverses 5-fluorouracil resistance in human colorectal cancer cells via inhibition the biosynthesis of polylactosamine-type N-glycans
Li Shen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Overcoming Cancer Multidrug Resistance by Codelivery of Doxorubicin and Verapamil with Hydrogel Nanoparticles
Ming Qin et al.
MACROMOLECULAR BIOSCIENCE (2014)
Protein Kinase Cα Protects Against Multidrug Resistance in Human Colon Cancer Cells
Se-Kyoung Lee et al.
MOLECULES AND CELLS (2012)
COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer
Hua Sui et al.
CARCINOGENESIS (2011)
RNA interference (RNAi) of Ufd1 protein can sensitize a hydroxycamptothecin-resistant colon cancer cell line SW1116/HCPT to hydroxycamptothecin
Xiang Chen et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
Yongsheng Wang et al.
BMC CANCER (2010)
Livin gene plays a role in drug resistance of colon cancer cells
Xudong Wang et al.
CLINICAL BIOCHEMISTRY (2010)
Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU
Guangming Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation
R. Fanciullino et al.
BRITISH JOURNAL OF CANCER (2007)
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy
Farnaz Taghizadeh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo
Li-Zong Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Antisense oligonucleotide-based therapeutics for cancer
NM Dean et al.
ONCOGENE (2003)
Exosomes:: Composition, biogenesis and function
C Théry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918
CMF Kruijtzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression
J Nagata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Gene therapy for colorectal cancer - Therapeutic potential
MJ Chen et al.
BIODRUGS (2001)
Share Paper
